BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34030118)

  • 1. Analysis of genes regulated by DUX4 via oxidative stress reveals potential therapeutic targets for treatment of facioscapulohumeral dystrophy.
    Karpukhina A; Galkin I; Ma Y; Dib C; Zinovkin R; Pletjushkina O; Chernyak B; Popova E; Vassetzky Y
    Redox Biol; 2021 Jul; 43():102008. PubMed ID: 34030118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients.
    Dmitriev P; Bou Saada Y; Dib C; Ansseau E; Barat A; Hamade A; Dessen P; Robert T; Lazar V; Louzada RAN; Dupuy C; Zakharova V; Carnac G; Lipinski M; Vassetzky YS
    Free Radic Biol Med; 2016 Oct; 99():244-258. PubMed ID: 27519269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: Metabolic stress as potential therapeutic target.
    Heher P; Ganassi M; Weidinger A; Engquist EN; Pruller J; Nguyen TH; Tassin A; Declèves AE; Mamchaoui K; Banerji CRS; Grillari J; Kozlov AV; Zammit PS
    Redox Biol; 2022 May; 51():102251. PubMed ID: 35248827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage.
    Bou Saada Y; Dib C; Dmitriev P; Hamade A; Carnac G; Laoudj-Chenivesse D; Lipinski M; Vassetzky YS
    Histochem Cell Biol; 2016 Apr; 145(4):475-83. PubMed ID: 26860865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?
    Tassin A; Laoudj-Chenivesse D; Vanderplanck C; Barro M; Charron S; Ansseau E; Chen YW; Mercier J; Coppée F; Belayew A
    J Cell Mol Med; 2013 Jan; 17(1):76-89. PubMed ID: 23206257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy.
    Bittel AJ; Sreetama SC; Bittel DC; Horn A; Novak JS; Yokota T; Zhang A; Maruyama R; Rowel Q Lim K; Jaiswal JK; Chen YW
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy.
    Moyle LA; Blanc E; Jaka O; Prueller J; Banerji CR; Tedesco FS; Harridge SD; Knight RD; Zammit PS
    Elife; 2016 Nov; 5():. PubMed ID: 27841748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1.
    Dixit M; Ansseau E; Tassin A; Winokur S; Shi R; Qian H; Sauvage S; Mattéotti C; van Acker AM; Leo O; Figlewicz D; Barro M; Laoudj-Chenivesse D; Belayew A; Coppée F; Chen YW
    Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18157-62. PubMed ID: 17984056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei.
    Vanderplanck C; Tassin A; Ansseau E; Charron S; Wauters A; Lancelot C; Vancutsem K; Laoudj-Chenivesse D; Belayew A; Coppée F
    Skelet Muscle; 2018 Jan; 8(1):2. PubMed ID: 29329560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling Serum Antibodies Against Muscle Antigens in Facioscapulohumeral Muscular Dystrophy Finds No Disease-Specific Autoantibodies.
    Greco A; Straasheijm KR; Mul K; van den Heuvel A; van der Maarel SM; Joosten LAB; van Engelen BGM; Pruijn GJM
    J Neuromuscul Dis; 2021; 8(5):801-814. PubMed ID: 34024774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia enhances human myoblast differentiation: involvement of HIF1α and impact of DUX4, the FSHD causal gene.
    Nguyen TH; Paprzycki L; Legrand A; Declèves AE; Heher P; Limpens M; Belayew A; Banerji CRS; Zammit PS; Tassin A
    Skelet Muscle; 2023 Dec; 13(1):21. PubMed ID: 38104132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies.
    Bosnakovski D; Xu Z; Gang EJ; Galindo CL; Liu M; Simsek T; Garner HR; Agha-Mohammadi S; Tassin A; Coppée F; Belayew A; Perlingeiro RR; Kyba M
    EMBO J; 2008 Oct; 27(20):2766-79. PubMed ID: 18833193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle.
    Banerji CRS; Panamarova M; Hebaishi H; White RB; Relaix F; Severini S; Zammit PS
    Nat Commun; 2017 Dec; 8(1):2152. PubMed ID: 29255294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression during normal and FSHD myogenesis.
    Tsumagari K; Chang SC; Lacey M; Baribault C; Chittur SV; Sowden J; Tawil R; Crawford GE; Ehrlich M
    BMC Med Genomics; 2011 Sep; 4():67. PubMed ID: 21951698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures.
    Haynes P; Kernan K; Zhou SL; Miller DG
    Skelet Muscle; 2017 Jun; 7(1):13. PubMed ID: 28637492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy.
    Banerji CR; Knopp P; Moyle LA; Severini S; Orrell RW; Teschendorff AE; Zammit PS
    J R Soc Interface; 2015 Jan; 12(102):20140797. PubMed ID: 25551153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell spatial transcriptomics reveals a dystrophic trajectory following a developmental bifurcation of myoblast cell fates in facioscapulohumeral muscular dystrophy.
    Chen L; Kong X; Johnston KG; Mortazavi A; Holmes TC; Tan Z; Yokomori K; Xu X
    Genome Res; 2024 Jun; 34(5):665-679. PubMed ID: 38777608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells.
    Jagannathan S; Shadle SC; Resnick R; Snider L; Tawil RN; van der Maarel SM; Bradley RK; Tapscott SJ
    Hum Mol Genet; 2016 Oct; 25(20):4419-4431. PubMed ID: 28171552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DUX4 expressing immortalized FSHD lymphoblastoid cells express genes elevated in FSHD muscle biopsies, correlating with the early stages of inflammation.
    Banerji CRS; Panamarova M; Zammit PS
    Hum Mol Genet; 2020 Aug; 29(14):2285-2299. PubMed ID: 32242220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-nucleus RNA-seq identifies divergent populations of FSHD2 myotube nuclei.
    Jiang S; Williams K; Kong X; Zeng W; Nguyen NV; Ma X; Tawil R; Yokomori K; Mortazavi A
    PLoS Genet; 2020 May; 16(5):e1008754. PubMed ID: 32365093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.